期刊文献+

重组人胱抑素C在大肠杆菌中的表达及纯化 被引量:1

Expression and purification of recombinant human cystatin C in Escherichia coli
在线阅读 下载PDF
导出
摘要 目的研究构建人胱抑素C(Cys C)的重组表达质粒及其在大肠杆菌中的表达和纯化。方法采用反转录-聚合酶链反应从人肝组织中获取Cys C cDNA,并将其插入到pET-28a(+)质粒中,重组质粒pET-28a-CysC转化入大肠杆菌E.coli BL21(DE3)pLysS,异丙基-β-D-硫代半乳糖苷(IPTG)诱导表达可溶性CysC。重组CysC采用Ni^2+-NTA系统进行层析纯化。结果核酸序列测定与预期一致,CysC表达水平达到146mg/L,约占菌体总可溶性蛋白的13.5%,表达产物用SDS-PAGE鉴定,其相对分子质量为13.3×10^3,经纯化后蛋白纯度达90%。结论成功构建Cys C原核表达系统和蛋白纯化,为制备抗体以及研制Cys C免疫纳米微球测定试剂奠定了基础。 Objective To study the construction of recombinant cystatin C gene plasmid and its expression in Escherichia coli(E, coli) and protein purification. Methods Cystatin C cDNA was isolated from liver tissue by reverse transcription polymerase chain reaction(RT-PCR), ligated into pET- 28a(+) vector, the construct was transformed into E. coli BL21(DE3)pLysS, then the recombinants of cystatin C was induced by IPTG, purified by affinity chromatography through Ni^2+-NTA. Results The acquired gene was 380 bp and its sequence was correct. The construct was expressed in E. coli with a high level as a soluble protein,accounting for 13.5% of the total batterial proteins. The gene product, characterized by SDS-PAGE appeared to be a protein with molecular mass of 13 300. The purity of the protein purified by affinity chromatography reached more than 90%0. Conclusion The success of construction,expression and purification of human cystatin C in E. coli provides basis for studying the preparation of polyclonal antibody and diagnostic reagent.
出处 《国际检验医学杂志》 CAS 2007年第5期393-394,共2页 International Journal of Laboratory Medicine
关键词 西司他汀类 质粒 大肠杆菌 基因表达 Cystatins Plasmids Escherichia coli Gene expression
  • 相关文献

参考文献3

  • 1Mussap M, Ruzzante N, Varagnolo M, et al. Quantitative automated particle-enhanced immunonephelometric assay for the routinary measurement of human eystatin C [J]. Clin Chem Lab Med, 1998, 36(11): 859-865.
  • 2Macisaac RJ, Tsalamandris C, Thomas MC, et al. Estimating glomerular filtration rate in diabetes: a comparison of cystatin-C-and creatinine-based methods[J]. Diabetologia, 2006, 49 (7) 1686-1689.
  • 3李海霞,李玉林,徐国宾,朱立华.重组人胱蛋白酶抑制剂C在毕氏酵母菌中的高效表达[J].中华检验医学杂志,2002,25(5):271-273. 被引量:6

二级参考文献7

  • 1Cregg JM,Vedvick TS,Raschke WC.Recent advances in the expression of foreign genes in Pichia pastoris[].Journal of Biotechnology.1993
  • 2Berti PJ,Ekiel I,Lindahl P,et al.Affinity purification and elimination of methionine oxidation in recombinant human cystatin C[].Protein Expression and Purification.1997
  • 3Mussap M,Ruzzante N,Varagnolo M,et al.Quantitative automated particle-enhanced immunonephelometric assay for the routinary measurement of human cystati n C[].Clinical Chemistry and Laboratory Medicine.1998
  • 4Sambrook J,Frisch EF,Maniatis T.Molecular Cloning, a Laboratory Manual[].nd ed Beijing: Science press.1995
  • 5Bobek LA,Levine MJ.Cystatins-inhibitors of cysteine proteinases[].Critical Reviews in Oral Biology and Medicine.1992
  • 6Kazama JJ,Kutsuwada K,Ataka K,et al.Serum cystatin C reliably detects renal dysfunction in patients with various renal diseases[].Nephron.2002
  • 7Abrahamson M,Olafsson I,Palsdottir A,et al.Structure and expression of the human cystatin C gene[].Biochemical Journal.1990

共引文献5

同被引文献7

  • 1冯建芳,汪淑荣,李平,赵一鸣,孙诠,师树古,陈明哲.急性心肌梗塞病人血清巯基蛋白酶抑制肽C的变化[J].基础医学与临床,1995,15(4):45-47. 被引量:20
  • 2Odutayo A,Chemey D. Cystatin C and acute changes in glomeru-lar filtration rate[ J]. Clin Nephrol, 2012,78(1) : 64-75.
  • 3Inker LA, Okparavero A. Cystatin C as a marker of glomerular fil-tration rate: prospects and limitations[ J]. Curr Opin Nephrol Hy, 2011,20(6): 631-639.
  • 4Taub PR,Borden KC,Fard A,et al. Role of biomarkers in the di-agnosis and prognosis of acute kidney injury in patients with cardiorenalsyndrome[ J] . Expert Rev Cardiovasc Ther,2012,10(5) : 657-667.
  • 5Muss呼 M, Ruzzante N, Varagnolo M,et al. Quantitative automatedpardcle-enhanced immunonephelometric assay for the routinary measuremetitof human cystatin C[J]. Clin Chem l^b Med, 1998 , 36(11) : 859-865.
  • 6Macisaac RJ, Tsalamandris C, Thomas MC, et al. Estimating glo-merular filtration rate in diabetes : a comparison of cystatin C and creati-nine-based methods[ J]. Diabetologia,2006 , 49(7) : 1686-1689.
  • 7Finney H, Newman DJ, Gruber W, et al. Initial evaluation of cys-tatin C measurement by particle-enhanced immunonephelometry on thebehring nephelometer systems( BNA, BN II) [ J] . Clin Chem, 1997,43(6):1016-1022.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部